Peter MacCallum Cancer Centre

Three Aussie startups that raised $18.75 million this week

Roundup of three Australian raises: Skopos Bio's $12m seed for targeted cancer radiopharmaceuticals, Trendspek's $6m for infrastructure condition AI, and R2Crete's $750,000 pre-seed for concrete recycling.

Also Startup Daily·This Week in Australian Startups·Cut Through Venture

Skopos Bio raises $8.4M seed to advance radioactive cancer therapy

Melbourne oncology startup Skopos Bio has raised a seed round from Tenmile, Tin Alley Ventures and Yosemite to advance radioactive cancer therapy toward human trials.

Currus Biologics: a tale of perseverance, persistence and patience

Profile of a Peter Mac spinout advancing solid-tumour cell therapies; recounts its Series A backers, later investment, grant support, and chief executive Sam Cobb's earlier career building and listing AdAlta.

Inside the Australian Life Sciences Boom: Renowned Investors, World-Class Partners, World-Leading Breakthroughs

Wholesale Investor's Steve Torso highlights Australian life sciences companies from the Emergence Preview Series, noting government grant funding, a Series A extension, venture co-investment, and a medtech company's ASX listing.

Also Wholesale Investor

Ferronova raises another $6 million to advance image-guided cancer surgery

Adelaide medtech Ferronova has banked another $6 million from returning backers to advance its surgical tracer for cancer, lifting Series A funding to $17.5 million; backer parent UltraGreen.ai floated in Singapore this month.

Also movefm.com.au

Biotech Ferronova boosts Series A capital raise by $6m

Adelaide biotech Ferronova added $6 million to its Series A from prior backers, lifting the round's total to $17.5 million; backer Renew's parent Ultragreen.ai floated in Singapore this month.

Also ferronova.com.au·movefm.com.au·Biotech Dispatch·Startup Daily

Our investment in Currus Biologics: Unlocking CAR-T for Solid Tumours

Main Sequence explains why it backed Currus Biologics, whose BEAT platform aims to make CAR-T cell therapies effective against solid tumours, starting with mesothelin-positive cancers, as the team prepares for a clinical trial.

Machine under development at Melbourne uses “vibrating bubbles” for super-speed bioprinting

University of Melbourne researchers describe a faster acoustic bioprinting method for human-like tissue; PhD candidate Callum Vidler's project recently won a $199,482 seed grant via the national AEA pilot program.

Professor got nothing from the $2.8b sale of his molecule, and that's okay

Profile of scientist-entrepreneur Andrew Wilks covering the GSK sale of his cancer molecule, his SYNthesis BioVentures fund's family-office backers, and portfolio plays including Aculeus Therapeutics.

Amaroq Therapeutics hits early milestones and makes key appointments to Scientific Advisory Board

Cancer biotech Amaroq Therapeutics appointed four experts to its advisory board as it moves toward clinical trials; the New Zealand company's backers include Brandon Capital, which reports $14m invested to date.

Amaroq Therapeutics hits early milestones and makes key appointments to Scientific Advisory Board

New Zealand biotech Amaroq Therapeutics reported early progress toward clinical trials and appointed four leading scientists to its scientific advisory board, strengthening its lncRNA cancer therapy programme.

Here are the winners of the first Governor of Victoria Startup Awards

Startup Daily reports the inaugural Governor of Victoria Startup Awards, where Amber Electric and Seer Medical shared the top prize, Linktree took scaleup honours, and the Allens' Tractor Ventures won investor recognition.

Also Startup Daily

The startup funding round: Beer delivery, AI-enabled upskilling, and $10 million for tech to treat cancer

Weekly roundup of Australian startup funding: Gilmour Space's $61m raise, rounds for Mindset Health, HowToo, Beer Cartel, Tracer DAO and Wimp 2 Warrior, Currus Biologics' $10m cancer-treatment raise, and Alberts' $16m impact fund.

Also Startup Daily·Startup Daily·Startup Daily·Startup Daily

Brandon Capital, Uniseed back cancer biotech start-up in $10m funding

Melbourne cancer immunotherapy startup Currus Biologics, spun out of Peter MacCallum, raised $10 million led by the Brandon Capital-managed Medical Research Commercialisation Fund with Uniseed, to advance its BEAT technology toward human trials.

Also Brandon BioCatalyst portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·SmartCompany·Startup Daily·SmartCompany·Startup Daily

Proacta Inc Announces Phase I Clinical Trial of Novel Prodrug to Target Hypoxic Tumors

Biotech Proacta's release: its Phase I cancer-drug trial is underway, and Alta Partners' new funding tops the Series A up to $12M alongside lead backer GBS Ventures; Alta's David Mack joins the board.